Report of two siblings with APECED in Serbia: is there a founder effect of c.769C>T AIRE genotype?
- PMID: 34078422
- PMCID: PMC8173724
- DOI: 10.1186/s13052-021-01075-8
Report of two siblings with APECED in Serbia: is there a founder effect of c.769C>T AIRE genotype?
Abstract
Background: Autoimmune polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) or autoimmune polyglandular syndrome Type 1 is a rare autosomal recessive syndrome. The disorder is caused by mutations in the AIRE (AutoImmune Regulator) gene. According to the classic criteria, clinical diagnosis requires the presence of at least two of three main components: chronic mucocutaneous candidiasis, hypoparathyroidism and primary adrenal insufficiency. Furthermore, patients are often affected by other endocrine or non-endocrine associated autoimmune conditions. The enrichment of the non-classical triad seems to occur differently in different cohorts. Screenings of the population revealed that homozygous AIRE mutations c.769C > T, c.415C > T and c.254A > G have a founder effect in Finnish, Sardinian and Iranian Jew populations respectively.
Case presentation: We report here the clinical and genetic characteristics of two new Serbian APECED siblings, one male and one female, actual age of 27 and 24 respectively, born from non-consanguineous parents. Addison's disease was diagnosed in the male at the age of 3.5 and hypoparathyroidism at the age of 4. The female developed hypoparathyroidism at 4 years of age. She presented diffuse alopecia, madarosis, onychomycosis, teeth enamel dysplasia. She further developed Addison's disease at the age of 11 and Hashimoto's thyroiditis at the age of 13.5. She had menarche at the age of 14 but developed autoimmune oophoritis and premature ovarian failure at the age of 16. A treatment with hydrocortisone, fludrocortisone and alfacalcidiol was established for both siblings; L-T4 (levo-thyroxine) for thyroid dysfunction and levonorgestrel and etinilestradiol for POF were also administered to the female. Genetic screening revealed a homozygous c.769C > T (R257X (p.Arg257X)) AIRE mutation. We additionally reviewed the literature on 11 previously published Serbian patients and evaluated the frequency of their main diseases in comparison to Finnish, Sardinian, Turkish, Indian and North/South American cohorts.
Conclusion: A founder effect was discovered for the R257X genotype detected in the DNA of 10 homozygous and 2 heterozygous patients. Of note, all Serbian APECED patients were affected by adrenal insufficiency and 10 out of 13 patients presented CMC.
Keywords: AIRE; APECED; Autoantibodies; Autoimmune polyglandular syndrome type 1; Genotype-phenotype variability; Serbian population.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Autoimmune polyendocrine syndrome type 1 (APECED) in the Indian population: case report and review of a series of 45 patients.J Endocrinol Invest. 2021 Apr;44(4):661-677. doi: 10.1007/s40618-020-01376-5. Epub 2020 Aug 7. J Endocrinol Invest. 2021. PMID: 32767280 Review.
-
Evaluation of the autoimmune regulator (AIRE) gene mutations in a cohort of Italian patients with autoimmune-polyendocrinopathy-candidiasis-ectodermal-dystrophy (APECED) and in their relatives.Clin Endocrinol (Oxf). 2009 Mar;70(3):421-8. doi: 10.1111/j.1365-2265.2008.03318.x. Epub 2008 Jun 27. Clin Endocrinol (Oxf). 2009. PMID: 18616706
-
Delay in the Diagnosis of APECED: A Case Report and Review of Literature from Iran.Immunol Invest. 2020 Apr;49(3):299-306. doi: 10.1080/08820139.2019.1671451. Epub 2019 Oct 7. Immunol Invest. 2020. PMID: 31588815 Review.
-
A Novel Homozygous Mutation of the AIRE Gene in an APECED Patient From Pakistan: Case Report and Review of the Literature.Front Immunol. 2018 Aug 13;9:1835. doi: 10.3389/fimmu.2018.01835. eCollection 2018. Front Immunol. 2018. PMID: 30150985 Free PMC article. Review.
-
Screening for an AIRE-1 mutation in patients with Addison's disease, type 1 diabetes, Graves' disease and Hashimoto's thyroiditis as well as in APECED syndrome.Clin Endocrinol (Oxf). 2001 Mar;54(3):335-8. doi: 10.1046/j.1365-2265.2001.01230.x. Clin Endocrinol (Oxf). 2001. PMID: 11298085
Cited by
-
Exploring Chronic Hypocalcemia: Insights into Autoimmune Polyglandular Syndrome Type 1-A Case Study and Literature Review.J Clin Med. 2024 Apr 18;13(8):2368. doi: 10.3390/jcm13082368. J Clin Med. 2024. PMID: 38673639 Free PMC article. Review.
-
New Approach to Addison Disease: Oral Manifestations Due to Endocrine Dysfunction and Comorbidity Burden.Diagnostics (Basel). 2022 Aug 28;12(9):2080. doi: 10.3390/diagnostics12092080. Diagnostics (Basel). 2022. PMID: 36140482 Free PMC article. Review.
-
The Spectrum of Disease-Associated Alleles in Countries with a Predominantly Slavic Population.Int J Mol Sci. 2024 Aug 28;25(17):9335. doi: 10.3390/ijms25179335. Int J Mol Sci. 2024. PMID: 39273284 Free PMC article. Review.
References
-
- Betterle C, Sabbadin C, Scaroni C, Presotto F. Autoimmune Polyendocrine syndromes (APS) or multiple autoimmune syndromes (MAS) In: Colao A, Jaffrain-Rea ML, Beckers A, editors. Polyendocrine disorders and endocrine neoplastic syndromes. Cham: Endocrinology Springer; 2019.
-
- Stolarski B, Pronicka E, Korniszewski L, Pollak A, Kostrzewa G, Rowińska E, Włodarski P, Skórka A, Gremida M, Krajewski P, Ploski R. Molecular background of polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome in a polish population: novel AIRE mutations and an estimate of disease prevalence. Clin Genet. 2006;70(4):348–354. doi: 10.1111/j.1399-0004.2006.00690.x. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources